uniQure Announces Successful Readministration of Gene Therapy in Non-Human Primates – Nasdaq
|
uniQure Announces Successful Readministration of Gene Therapy in Non-Human Primates
Nasdaq LEXINGTON, Mass. and AMSTERDAM, the Netherlands, May 11, 2017 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today presented … |
